ANTIBODY SHOP

Services
Name:
Phone:
E-mail:
Message

F12 | Coagulation factor XII

304 €

IMS01-137-306  |  clonality: polyclonal  |  host: hen  |  rectivity: human

PRODUCT INFORMATION IN PDF

Qty: 
Availability:
7 st
Delivery:
Shipping:
Item No:
IMS01-137-306

Info: Product suggestions Add review
product information
Background

Coagulation factor XII circulates in blood as a zymogen. This single chain zymogen is converted to a two chain serine protease with an heavy chain (alpha factor XIIa) and a light chain. The heavy chain contains two fibronectin type domains, two epidermal growth factor (EGF) like domains, a kringle domain and a proline rich domain, whereas the light chain contains only a catalytic domain. On activation, further cleavages takes place in the heavy chain, resulting in the production of beta factor XIIa light chain and the alpha factor XIIa light chain becomes beta factor XIIa heavy chain. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha factor XIIa and then to beta factor XIIa. The active factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. It activates coagulation factors VII and XI. Defects in Factor XII gene do not cause any apparent clinical symptoms and the sole effect is that whole blood clotting time is prolonged.

Immunogen

purified full length native protein P00748

Host Hen
Clonality Polyclonal
Clone
Purity Total IgY fraction
Format Liquid in 0.9% NaCl, 0.1% sodium azide
Quantity 100 ĩl (15.1 mg/ml)
Reconstitution
Storage

store at 4°C; make aliquots to avoid working with a stock. Please, remember to spin tubes briefly prior to opening them to avoid any losses that might occur from liquid material adhering to the cap or sides of the tubes.

Tested applications ELISA (ELISA)
Related products

IMS01-118-307 | anti-Coagulation factor VII

AS00 001 | anti-Coagulation factor VIIa

IMS01-015-308 | anti-Coagulation factor VIII

AS05 058 | anti-Coagulation factor IX

Secondary antibodies

Additional information
application information
Recommended dilution

1: 10 000 (ELISA)

Expected | apparent MW

67 kDa

Confirmed reactivity

human

Predicted reactivity

human

Not reactive in

no confirmed exceptions from predicted reactivity known in the moment

Additional information

detects human coagulation factor XII and XIIa

Selected references

to be added when available



||| For other applications, usage on species other than stated above or any other questions, please use the LiveChat option or contact us at support@agrisera.com